Stroke Clinical Trials in Atlanta, Georgia
11 studies are recruiting for stroke in Atlanta, Georgia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
This is a Phase 2/3 study evaluating the safety and efficacy of DM199 (rinvecalinase alfa) in treating participants with moderate stroke severity, who present within 24 hours of Acute Ischemic Stroke (AIS) onset due to small and medium vessel occlusions. This study focuses on participants with limi…
- Stage
- Phase 2
- Ages
- 18 to 90
- Site
- Emory University/Grady Memorial Hospital, Atlanta, Georgia
- Locations
- 86 in total
- Run by
- DiaMedica Therapeutics Inc
-
Telerehabilitation In The Home After Stroke
The purpose of this research study is to evaluate whether telerehabilitation targeting arm movement, when added to usual care, improves arm function and reduces global disability after stroke, compared to usual care alone. Patients with arm weakness due to stroke that happened in the past 90-150 da…
- Stage
- Not phased
- Ages
- 18 to 80
- Site
- Emory Rehabilitation Hospital, Atlanta, Georgia
- Locations
- 27 in total
- Run by
- University of California, Los Angeles
-
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
TESTED will compare the risks and benefits of endovascular thrombectomy (EVT) to medical management (no EVT) in ischemic stroke patients who have a blockage in one of the large blood vessels in the brain and have a moderate-to-severe disability prior to their stroke.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Emory University, Atlanta, Georgia
- Locations
- 35 in total
- Run by
- University of Cincinnati
-
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore these biomarkers in acute intracerebral hemorrhage. VERIFY will create the first multicenter, large-scale, prospective dataset of clinical, tra…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Emory University Hospital, Atlanta, Georgia
- Locations
- 45 in total
- Run by
- Yale University
-
Neuroplastic Changes Due to an Exercise Intervention That Aid in Lower Limb Recovery After Subcortical Stroke
This study aims to develop imaging-based biomarkers to assess which chronic stroke participant with lower extremity disability may respond or resist high intensity interval training (HIIT). Previous research suggests that physical exercise training is safe and could help improve the walking speed o…
- Stage
- Not phased
- Ages
- 18 to 80
- Site
- Emory Rehabilitation Hospital, Atlanta, Georgia
- Locations
- 2 in total
- Run by
- Emory University
-
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
This study will assess the safety and effectiveness of GORE® CARDIOFORM Septal Occluder in a post approval setting and evaluate the quality of operator education and training and transferability of trial experience to a post-market setting.
- Stage
- Not phased
- Ages
- 18 to 70
- Site
- Emory University, Atlanta, Georgia
- Locations
- 45 in total
- Run by
- W.L.Gore & Associates
-
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
The primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet therapy in patients who develop new-onset post-operative atrial fibrillation (POAF) after isolated c…
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- Emory University, Atlanta, Georgia
- Locations
- 106 in total
- Run by
- Icahn School of Medicine at Mount Sinai
-
Spatial-Motor Stroke-Rehab Study
The purpose of this study is to understand how prism adaptation training with and without electrical stimulation changes visuospatial behavior, motor system neurophysiology, and walking dysfunction.
- Stage
- Not phased
- Ages
- 18 to 90
- Site
- Emory Rehabilitation Hospital, Atlanta, Georgia
- Locations
- 3 in total
- Run by
- Emory University
-
Efficacy and Sustainability of a Carepartner-Integrated Telerehabilitation Program for Persons With Stroke
Stroke is a leading cause of long-term disability. Research has placed little emphasis on integrating care partners (CP) (family members) into the rehabilitation process without increasing negative care partner outcomes. The research team has developed and implemented a novel, web-based care partne…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Emory Rehabilitation Hospital, Atlanta, Georgia
- Run by
- Emory University
-
Stroke Thrombectomy and Aneurysm Registry
This international multi-center registry is used to collect existing information and outcomes for patients undergoing an operation for treatment of injuries to the brain including the blockage of blood flow to an area of the brain, an abnormal ballooning of an artery, abnormal tangling of blood ves…
- Stage
- Not phased
- Ages
- 1 to 120
- Site
- Piedmont Healthcare, Atlanta, Georgia
- Locations
- 63 in total
- Run by
- Medical University of South Carolina
-
Dysphagia Study Using Novel Microphone Device
This study aims to collect swallowing acoustics with a novel non-invasive wearable surface microphone device during routine work-up, videofluoroscopic swallow study (VFSS), of patients with dysphagia (swallowing trouble). The collected microphone data will be analyzed to find the pattern of abnorma…
- Stage
- Not phased
- Ages
- 40 to 85
- Site
- Emory University Hospital Midtown, Atlanta, Georgia
- Locations
- 2 in total
- Run by
- Emory University
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.